Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of SUN11031 for eating disorders
jRCT2080220697Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anorexia nervosa (AN) and Eating Disorder Not Otherwise Specified (EDNOS) comparing SUN11031 2.0 μg/kg with Placebo (2 arms).
02
Drugs
SUN11031
03
Conditions
anorexia nervosa (AN)Eating Disorder Not Otherwise Specified (EDNOS)
Beyond the preview
Go deeper on jRCT2080220697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220697.